Clinical Trial Update: Phase I/II Dose Ranging CHRONSEAL® Study in Venous Leg Ulcers [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II dose-ranging clinical trial evaluating CHRONSEAL for chronic venous leg ulcers, sponsored by Kringle Pharma Europe AB; status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Ulcers

Drugs mentioned

• CHRONSEAL

Snippet

Sponsor: Kringle Pharma Europe AB | Conditions: Chronic Venous Leg Ulcers | Phase 1, Phase 2 | Status: UNKNOWN